When was Fountain Medical Development founded?

Fountain Medical Development was founded in 1995 and raised its 1st funding round 24 years after it was founded.

Where is Fountain Medical Development located?

Fountain Medical Development is headquartered in Shanghai, China.

How many employees does Fountain Medical Development have?

As of May 31, 2026, the latest employee count at Fountain Medical Development is 53.

Is Fountain Medical Development a funded company?

Fountain Medical Development is a funded company, having raised a total of $***** in its 1st and only funding round, a Series D round on Oct 25, 2019.

When was the latest funding round of Fountain Medical Development?

Fountain Medical Development's latest funding was a $***** Series D round on Oct 25, 2019, with participation from 2 investors. Its primary sector is Biopharma Outsourcing. In China, the Biopharma Outsourcing sector has seen $50.6M in funding in 2026 to date.

Where does Fountain Medical Development rank among its competitors?

Fountain Medical Development ranks 11th amongst 339 active competitors, of which 14 are funded. It stands 2nd in terms of total funding among its competitors. The most recent competitor to raise funding was ClinChoice, which secured $150M in Jul, 2022.

Who are the top competitors of Fountain Medical Development?

Fountain Medical Development's top competitors include Parexel, Celgene and Veristat. Among them, ClinChoice secured the most recent funding round in July, 2022.

Fountain Medical Development - 2026 Company Profile, Funding & Competitors

Fountain Medical Development is an acquired company based in Shanghai (China), founded in 1995. It operates as a Full-service CRO based out of China and East Asia. Fountain Medical Development has raised $62M in funding from Goldman Sachs. The company has 339 active competitors, including 14 funded and 112 that have exited. Its top competitors include companies like Parexel, Celgene and Veristat.

Company Details

Full-service CRO based out of China and East Asia. They offer consulting, project management, regulatory affairs, site management, clinical trial design, clinical operations, and central laboratory services.

Key Metrics

Founded Year

1995

Location

Shanghai, China

Stage

Acquired

Total Funding

$62M in 1 round

Latest Funding Round

Series D, Oct 25, 2019, $*****

Investors

Goldman Sachs & 10 more

Ranked

11^th among 339 active competitors

Employee Count

53 as on May 31, 2026

Similar Companies

Parexel & 404 more

Exit Details

Acquired by FMD K&L (Sep 01, 2014)

View Fountain Medical Development's full profile

Fountain Medical Development got acquired by FMD K&L on Sep 01, 2014.

Click here to take a look at Fountain Medical Development's acquisition in detail

Fountain Medical Development has raised a total funding of $62M over 1 round. Its latest funding round was a Series D round on Oct 25, 2019 for $*****. 2 investors participated in its latest round. Fountain Medical Development has 11 institutional investors.

Here is the list of recent funding rounds of Fountain Medical Development:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Oct 25, 2019	2197106	Series D	4067406	4784823	3732199	6973884

Access funding benchmarks and valuations. Sign up today!

View details of Fountain Medical Development's funding rounds and investors

Fountain Medical Development's employee count trend

Fountain Medical Development has 53 employees as of May 26. Here is Fountain Medical Development's employee count trend over the years:

Employee count trend for Fountain Medical Development

Uncover Fountain Medical Development's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Fountain Medical Development include Parexel, Celgene and Veristat. Here is the list of Top 10 competitors of Fountain Medical Development, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Parexel 1983, Waltham (United States), Acquired	Global full-service CRO	-	Vedanta Capital, Boston Capital Ventures & 2 others	61/100
2nd	Celgene 1986, Summit (United States), Acquired	Developer of therapies for treating cancer and inflammatory diseases	$45M	Piper Jaffray, Gershon Capital & 12 others	61/100
3rd	Veristat 1994, Southborough (United States), Acquired	Clinical research organization accelerating complex therapies through strategic planning and execution	-	Variance Development Partners, WindRose Health Investors ... & 2 others	60/100
4th	Siro Clinpharm 2000, Thane (India), Acquired	Company offering clinical development services	$5.25M	Kotak Mahindra Bank, Baring Private Equity Partners ... & 4 others	60/100
5th	TFS 1996, Lund (Sweden), Acquired	A global mid-service CRO providing clinical research services	-	Comvest Partners	59/100
6th	Syneos Health 1984, Raleigh (United States), Public	Provider of CRO clinical development	-	Adams Street Partners, Nordea & 3 others	58/100
7th	Premier Research 1989, Durham (United States), Public	Provider of clinical trial CRO services	-	alzheimerlondon.ca, HarbourVest Partners & 4 others	55/100
8th	Biorasi 2002, Miami (United States), Acquired	CRO delivering reliable, flexible, transparent clinical trials with scientific excellence	-	-	54/100
9th	ClinChoice 1995, Fort Washington (United States), Series E	CRO focused on data management, regulatory affairs and consulting services	$212M	Legend Capital, Goldman Sachs & 8 others	53/100
10th	Worldwide Clinical Trials 1986, Beverly Hills (United States), Acquired	Global CRO providing personalized support for clinical trials across diverse therapeutic areas	-	TJC, Scrip Awards	52/100
11th	Fountain Medical Development 1995, Shanghai (China), Acquired	Full-service CRO based out of China and East Asia	$62M	Draper Dragon, Cowin Capital & 9 others	49/100